ARCHIVES

ACOS Survey To Assess Tumor Boards’ Impact On Patient Care

This article is from The Cancer Letter archive.

Vol. 12 No. 04 | January 24, 1986

Download PDF Visit The Full Archive

Related Articles

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

Heart Function Of Breast Cancer Patients Should Be Monitored, Two Studies Find

August 25, 2006

The Clinical Cancer Letter To End Print Edition In 2010

November 27, 2009

Advisors’ Report On Intramural Program To Recommend Restructuring

April 14, 1995

Directory Of NCI Numbers Available

March 22, 1985

Unscreened Women At High Risk of Breast Cancer

October 29, 2004